Michael Makris: When a Researcher Is Listed as First Author Without Knowing
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at University of Sheffield, Editor-in-Chief of Research and Practice in Thrombosis and Haemostasis, shared Eric Topol‘s post on LinkedIn:
“This is incredible.
The first author had nothing to do with this paper, and he was added as the main author without his consent!
I note that the corresponding author lists their position at a prestigious US university.
Vanderbilt University has a moral and scientific obligation to investigate and openly report back to the scientific community about what happened here.
The journal and its publisher should also issue a statement about their policies and what went wrong in this case.”
Eric Topol, Founder and Director of Scripps Research Translational Institute, shared a post on LinkedIn:
“This is a fraudulent paper, AI-generated.
My name was used as an author and I had nothing to do with it, never saw it until today.
The ‘Editors’ Angelo Rossi Mori, David Mensah, and Zarnie Khadjesari and this ‘Journal’ should be reported.”

Other posts featuring Michael Makris and Eric Topol on Hemostasis Today.
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials